Related Experiment Video
Updated: Apr 18, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human
Luis M Beltrán1, Alfonso Rubio-Navarro2, Juan Manuel Amaro-Villalobos2
1Metabolic-Vascular Unit, Fundación IdiPAZ-Hospital Universitario La Paz, Madrid, Spain.
Insights
Human immunodeficiency virus (HIV) infection increases cardiovascular risk. HIV-related inflammation, immune activation, and endothelial dysfunction drive atherosclerosis development and progression, independent of antiretroviral therapy.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Patients with human immunodeficiency virus (HIV) exhibit elevated cardiovascular disease (CVD) risk.
- Antiretroviral therapy (ART)-associated metabolic changes were initially blamed, but HIV disease pathogenesis is now recognized as a primary driver.
- Chronic inflammation, immune dysregulation, and endothelial dysfunction inherent to HIV infection contribute significantly to CVD.
Purpose of the Study:
- To review the epidemiology and pathogenesis of CVD in the context of HIV infection.
- To synthesize current understanding of how HIV disease itself impacts cardiovascular risk.
- To examine the role of traditional and novel biomarkers in assessing CVD risk in HIV-positive individuals.
Main Methods:
- Literature review synthesizing epidemiological data on CVD in HIV.
- Analysis of pathogenetic mechanisms linking HIV infection to atherosclerosis.
- Evaluation of biomarkers related to inflammation, immune activation, and endothelial function.
Main Results:
- HIV infection independently elevates cardiovascular risk.
- Inflammation, immune activation, and endothelial dysfunction are key mechanisms.
- Biomarkers of these processes are crucial for risk stratification in HIV patients.
Conclusions:
- HIV disease, not solely ART, is a major contributor to accelerated atherosclerosis.
- Understanding HIV-specific inflammatory and immune pathways is vital for CVD prevention.
- Novel biomarkers offer potential for improved cardiovascular risk assessment in HIV-infected populations.
Abstract:
Patients infected with the human immunodeficiency virus (HIV) have an increased cardiovascular risk. Although initially this increased risk was attributed to metabolic alterations associated with antiretroviral treatment, in recent years, the attention has been focused on the HIV disease itself. Inflammation, immune system activation, and endothelial dysfunction facilitated by HIV infection have been identified as key factors in the development and progression of atherosclerosis. In this review, we describe the epidemiology and pathogenesis of cardiovascular disease in patients with HIV infection and summarize the latest knowledge on the relationship between traditional and novel inflammatory, immune activation, and endothelial dysfunction biomarkers on the cardiovascular risk associated with HIV infection.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Sexually Transmitted Infections
Myocarditis I: Introduction
Inflammatory Response I: Vascular and Cellular
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

